Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05907954 · ClinicalTrials.gov registry record · Phase 2

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

A Phase 2 study of Uveal Melanoma, sponsored by IDEAYA Biosciences.

Active
Registry status
Phase 2
Development phase
160
Enrollment target
18
Study locations

NCT05907954 is a Phase 2 study of Uveal Melanoma that is active but no longer recruiting, run by IDEAYA Biosciences. The registered enrollment target is 160 participants, above the 140-participant average among 29 other Uveal Melanoma trials with a reported enrollment target (14% higher). The trial reports 18 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05907954, a Phase 2 study of Uveal Melanoma, is active but no longer recruiting, sponsored by IDEAYA Biosciences.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
160 participants
Enrollment target
18
Study locations

Study Summary

Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma

Conditions Studied

Uveal Melanoma

Interventions

  • DRUG Darovasertib

Study Locations (18)

Other

  • Institute Curie - Paris
  • Charité - Universitätsmedizin Berlin - Berlin
  • Fondazione IRCCS Istituto Nazionale Tumori - Milan
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Rome
  • Leiden University Medical Center - Leiden

California

  • Moores Cancer Center - La Jolla
  • Stanford Cancer Institute - Palo Alto

Arizona

  • HonorHealth Research Institute - Scottsdale

Florida

  • University of Miami - Miami

Michigan

  • The Cancer and Hematology Centers - Grand Rapids

Minnesota

  • Mayo Clinic Rochester - Rochester

New York

  • Northwell - Manhasset

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2023-07-03
Est. Completion 2030-04-30
Phase Phase 2

Sponsor

IDEAYA Biosciences

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05907954

The ClinicalTrials.gov registry entry for NCT05907954 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 140-participant average among 29 other Uveal Melanoma trials with a reported enrollment target (14% higher). The listed sponsor is IDEAYA Biosciences, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Uveal Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Darovasertib is the first listed.

NCT05907954 reports 18 study locations spanning 13 distinct geographic areas - top geographies include Other, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT05907954 about?

NCT05907954 is a clinical study titled "(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma". Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma

What is the current status of trial NCT05907954?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2023-07-03. Estimated completion is 2030-04-30.

What conditions does trial NCT05907954 study?

This clinical trial studies the following conditions: Uveal Melanoma.

What interventions are being tested in trial NCT05907954?

The interventions under investigation include: Darovasertib (DRUG).

Who is sponsoring clinical trial NCT05907954?

This trial is sponsored by IDEAYA Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05907954 being conducted?

This trial has 18 study locations across Arizona, California, Florida, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Uveal Melanoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Uveal Melanoma

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.